Construction of a Risk Screening Tool for New Psychoactive Substance Misuse Among Adolescents and Young Adults
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age14-35
SponsorWei XIA, PhD
About this trial
The goal of this observational study is to construct a risk tool available for screening young adults and adolescents at high risk of drug misuse and provides a chance for early intervention to young adults and adolescents at high risk of drug misuse, which prevent the onset and development of drug addiction in the future.The main question it aims to answer is:
1. Explore the occurrence and influencing factors of new psychoactive substance misuse among young adults and adolescents; 2. Construct a risk prediction model for new psychoactive substance misuse among young adults and adolescents and conduct internal verification of the model; 3. Based on the results of the prediction model, select the optimal model to initially form a concise scale "Screening Tool for the Risk of New Psychoactive Substance Misuse among Young Adults and Adolescents"; 4. Conduct external verification of the tool, and revise and improve the screening tool, form the final version of the screening tool, and verify the application performance of the screening tool.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adolescents and young adults who were aged 14-35 years;
Adolescents and young adults could read and communicate in Chinese were invited to participate in this study
Disqualifiers
Adolescents and young adults who were unable to complete the questionnaire due to physical or psychological reasons.
Trial population
Adolescents and young adults aging 14-35 years old
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
Questionnaire and Physical Exam
Other interventionThe investigators use questionnaire to assess biological factors (sleep quality, externalizing problem behavior, prosocial tendencies, sensation seeking, and hedonic hunger), psychological factors (risk awareness of drug misusing, indulgence of drug misusing, self-efficacy of drug misusing, and ACEs), and social factors (whether work in a special place, whether have drug-addicts around, cognition of traditional drug types, and cognition of NPS types) and demographic data
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Perceived risks associated with drug abuse
Perceived risks associated with drug abuse developed by the Hong Kong Security Bureau's Narcotics Division is adopted (https://www.nd.gov.hk/tc/beat\_questions\_2010R2.html). The scale consists of 12 questions and uses a 5-point Likert scale (1 = Strongly Disagree, 2 = Disagree, 3 = Unsure, 4 = Agree, 5 = Strongly Agree). The total score ranges from 12 to 60, with a higher score indicating a greater awareness of drug use risks. In this study, the Cronbach's α coefficient for the Chinese version of this scale is 0.931.
Time frame
baseline2
Pittsburgh Sleep Quality Index (PSQI)
The Pittsburgh Sleep Quality Index was developed by Buysse et al. \[14\], and the Chinese version was translated and revised by Xianchen Liu et al. in 1996 \[15\]. It has been confirmed that the PSQI is suitable for evaluating sleep quality in patients with mental disorders and the general population in China. This scale consists of 19 self-reported items and 5 observer-rated items, of which the 19th self-reported item and the 5 observer-rated items are not included in the scoring. The 18 items comprise seven factors: sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction. Each component is scored on a scale from 0 to 3, with a total score range from 0 to 21. A higher score indicates poorer sleep quality. In this study, the overall Cronbach's α coefficient for the Chinese version of the scale across the seven factors was 0.716.
Time frame
baseline3
Prosocial Tendencies Measure (PTM)
The Chinese version of the Prosocial Tendencies Measure was revised by Yu Kou, Huifang Hong et al. in 2007 \[16\]. This scale consists of 26 items, encompassing six dimensions: public, anonymous, altruistic, compliant, emotional, and urgent. It uses a 5-point Likert scale for scoring (1 = very unlike me, 2 = somewhat unlike me, 3 = neutral, 4 = somewhat like me, 5 = very like me). The total score ranges from 26 to 130, with higher scores indicating greater prosocial tendencies. In this study, the Cronbach's α coefficient for the Chinese version of the scale was 0.957, with the Cronbach's α coefficients for the six dimensions of public, anonymous, altruistic, compliant, emotional, and urgent being 0.824, 0.877, 0.845, 0.849, 0.855, and 0.791, respectively.
Time frame
baseline4
Achenbach Youth Self Report (YSR)
The Youth Self Report (YSR), developed by Achenbach et al. \[17\], was used in its 2001 version. The Chinese version was translated and revised by Wang Runcheng et al.\[18\] in 2013. The questionnaire is divided into 8 factors (Anxiety/Depression, Withdrawn/Depressed, Somatic Complaints, Social Problems, Thought Problems, Attention Problems, Delinquent Behavior, Aggressive Behavior) and an "Other Problems" item. The Delinquent Behavior and Aggressive Behavior factors together constitute the externalizing symptom group and are widely used to measure externalizing problem behaviors in adolescents. The Delinquent Behavior factor includes 15 items, and the Aggressive Behavior factor includes 17 items, using a three-point scoring scale (0 = not at all true, 1 = somewhat true, 2 = very true). The total score for the two factors ranges from 0 to 96, with higher scores indicating more severe externalizing problem behaviors. In this study, the Cronbach's α coefficients for the Delinquent Behavior
Time frame
baselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Wei XIA, PhD
Lead sponsor
Sun Yat-sen University
Sponsor institution
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: